drugset
drugset / Trial / NCT02291341

Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition

NCT02291341 ↗

Phase 1 Completed 76 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

This study were to compare the relative bioavailability of Duloxetine HCl delayed release capsule 60 mg with that of 'CYMBALTA®' delayed release capsule 60 mg (Duloxetine HCl delayed release capsule 60 mg) in healthy, adult, human subjects under fed conditions and to monitor safety of subjects

Timeline

Start
2008-05
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications

No indication recorded.